Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Default BP Medication Intensification [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/Phase 2 trial examining default intensification of antihypertensive therapy in hypertension. The study was conducted at Cedars-Sinai Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Hypertension | Phase 1, Phase 2 | Status: TERMINATED